Why this matters now As explored in his recent article in Hydrocarbon Engineering magazine, Emerson’s Dave Denison—an expert with over 25 years in the automation industry—explains that many organizations are hitting diminishing returns from plant‑level digital...
Why this matters now One of the consequences of a vast improvement in the capability and affordability of sensing devices over the last few years has been a significantly increased risk of overwhelming operational technology (OT) teams with too much data. Data is...
Life sciences may be the ideal industry for the implementation of AI technologies. After all, bringing a treatment all the way through the drug development process is an extremely complicated undertaking, with tremendous amounts of data and a wide array of...
Cybersecurity is not and never has been a set-and-forget solution. Every day attackers identify new strategies and exploits they can use to create havoc across global infrastructure. But cybersecurity software rarely—if ever—feels like a value-add. For process...
AI is changing drug discovery faster than most people expected. Commercial manufacturing is next. The organizations best positioned for that shift are the ones preparing now, not because they’re behind, but because the window to prepare thoughtfully is exactly when...
Allowing equipment to run to failure is no longer a viable option for the mining industry. With increasing competition around the world, margins have decreased sharply, and mining organizations are feeling increasing pressure to eliminate downtime and potential...
Why this matters now As detailed in his recent article in Control Engineering, Emerson’s Brian LaMothe, a recognized industry expert, explains that operators can no longer rely on plant‑level improvements alone. The most competitive organizations are modernizing...
In the wake of the COVID-19 pandemic and the associated development of a vaccine in record time, the biopharmaceutical industry has seen significant change. Today, we know that faster development is possible, though it is still challenging. That has increased the...
Why this matters now As explored in his recent article in Smart Industry, Emerson’s Dave Denison—leveraging more than two decades of automation expertise—explains that AI, machine learning, and advanced control workloads are pushing traditional controllers beyond...
In Part 1, we explored why digital strategies that sit above operations break down in regulated life sciences manufacturing. When analytics are disconnected from validated execution, insight loses the context required to support quality, compliance, and release...
Why this matters now As explored in his recent article in Control Engineering, Emerson’s Dave Denison—leveraging his decades of experience in the automation industry—explains that OT teams face a unique challenge as AI adoption accelerates. While AI is gaining...
The common digital strategy playbook is: unify the data, layer on AI, and drive enterprise-level insight. The strategy sounds compelling in its simplicity. And for some industries and some use cases, it can work. But in regulated life sciences manufacturing, there is...
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.
Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.
Our Global Community
Emerson Exchange 365
This blog features expert perspectives from Emerson's automation professionals on industry trends, technologies, and best practices. The information shared here is intended to inform and educate our global community of users and partners.